Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

Delayed Data
As of Oct 02
 +0.28 / +0.75%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 14 analysts offering 12-month price forecasts for Myriad Genetics Inc have a median target of 35.50, with a high estimate of 47.00 and a low estimate of 25.00. The median estimate represents a -6.01% decrease from the last price of 37.77.

Analyst Recommendations

The current consensus among 19 polled investment analysts is to Hold stock in Myriad Genetics Inc. This rating has held steady since October, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -14.60%
Growthannually 12.39%


Growthquarterly -6.42%
Growthannually 4.67%
Key to the earnings and sales forecast charts.